Recognition of cmv infected cells by t-cells engineered to express cmv-specific chimeric immunereceptor

Projektinformationen

LARSSON, KAJSA

ID Finanzhilfevereinbarung: QLK2-CT-2002-51656

Startdatum 1 Februar 2003

Enddatum 31 Januar 2005

Finanziert unter

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Gesamtkosten € 147 150,00

EU-Beitrag € 147 150,00

Koordiniert durch

THE UNIVERSITY OF TUEBINGEN
Germany

Ziel

Our aim is to construct a chimerical CMV-specific immune receptor and link it to the surface of catatonic T-Cells, thereby creating a CMV-specific immune defence to patients who are at great risk of dying from CMV after transplantation.

Wissenschaftliches Gebiet

• medical and health sciences › clinical medicine › transplantation

Programm/Programme

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Thema/Themen

• 1.1.1.-2. - Key action Control of Infectious Diseases

Aufforderung zur Vorschlagseinreichung

Data not available

Finanzierungsplan

RGI - Research grants (individual fellowships)

Koordinator

THE UNIVERSITY OF TUEBINGEN

• EU-Beitrag: Keine Daten
• Adresse: Otfried-Mueller-strasse 10 ; 72076 TUEBINGEN ; Deutschland
• Gesamtkosten: Keine Daten